CD19 and acute lymphoblastic leukemia: The data available on CAR-T cells, mostly directed against CD19 and used for the treatment of acute lymphoblastic leukemia (ALL) and B-non Hodgkin’s lymphoma (B-NHL), are however informative in this regard.